As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...